Method of cell growth inhibition with agnoprotein
US7612039B2 · kind B2 · utility
1Cited by
5References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 11, 2003 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Jan 18, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The growth of normal and abnormally proliferating cells can be inhibited by the introduction of agnoprotein, or biologically active fragments or derivatives of agnoprotein, into the cell in the absence of any other polyoma virus protein or viral replication.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.